Proliferative Diabetic Retinopathy

In reponse to poor circulation in the retina from diabetic retinopathy, new blood vessels sometimes grow. This is called proliferative diabetic retinopathy.

Does proliferative retinopathy Always Affect Vision?

No it does not always affect vision. It is possible to have advanced, sight threatening, proliferative diabetic retinopathy with normal vision. Proliferative diabetic retinopathy is an advanced for of diabetic eye disease. "Proliferative" means that there is growth, or "proliferation," of abnormal blood vessels in the back of the eye. Sometimes, very severe growth of abnormal blood vessels can also affect the front part of the eye. Proliferative diabetic retinopathy is a marker that diabetes has been present and poorly controlled for a long time. One of the theories that explains why abnormal new blood vessel growth occurs in diabetic eyes is that, as the normal small blood vessels in the eye become diseased and stop working well, the remaining vasculature begins to sprout new abnormal blood vessels. Often there vision is normal when proliferative abnormal blood vessel growth starts, which is one of the reasons it is vital that all diabetics receive regular dilated eye exams.

Proliferative Diabetic Retinopathy Treatment

Treatment for proliferative diabetic retinopathy has evolved over the last several decades. One of the most important aspects of treatment remains optimizing the blood sugar and systemic health in diabetes, since there is no way to completely stop diabetic retinopathy from getting worse when blood sugar, blood pressure, and other vascular diseases are under poor control. The mainstay of eye treatment for proliferative diabetic retinopathy remains a retinal laser procedure, called panretinal photocoagulation (PRP). PRP is performed in the office with either anesthesia drops or an anesthetic injection. It is very well-tolerated by patients, and has been shown repeatedly to reduce the risk of severe vision loss from proliferative diabetic retinopathy. Often, several sessions of panretinal photocoagulation are necessary. It is very important to understand that PRP laser treatment is not a cure for proliferative diabetic retinopathy, as there is no known cure for diabetes or its affects in the body. PRP treatment is very safe, and often helps keep patients from more invasive and extensive surgical procedures. Like every medical procedure, there are potential risks and side-effects to PRP laser. The specific risks and benefits of this type of laser will be discussed with every patient on an individualized basis.

What about Vitrectomy Surgery?

When proliferative diabetic retinopathy is advanced, vitrectomy surgery becomes necessary. That's why screening examinations are important so patients can be treated with laser before the proliferative retinopathy becomes so severe that surgery is necessary. Surgery can substantially reduce the risk of vision loss from severe proliferative diabetic retinopathy, but it does carry a risk from 10 percent to 20 percent of severe vision loss.

Nonclearing vitreous hemorrhage
  Traction retinal detachment involving the macula
  Combined tractional-rhegmatogenous retinal detachment
  Progressive active fibrovascular proliferation
  Macular edema associated with posterior hyaloidal traction
  Dense premacular hemorrhage
  Dense vitreous hemorrhage in the presence of anterior segment neovascularization

What about Anti-VEGF Therapy?

In addition to PRP laser, injectable therapy with anti-vascular endothelial growth factor (VEGF) medications has more recently played a role in the treatment of proliferative diabetic retinopathy. This is, at the moment, not an FDA approved treatment of proliferative retinopathy and is used sometimes to augment the affect of laser, not to replace laser. Since the mid-to-late 2000's, injections into the eye of small molecule antibody drugs have been shown to effectively treat the growth of abnormal new blood vessels. There are a variety of injectable drugs available, and these drugs are sometimes used on their own and are often combined with PRP laser treatment to cause the abnormal new blood vessels to stop growing. The injections are often used before there is extensive growth of abnormal new blood vessels. Injection therapy is administered in the office with either anesthetic drops or an anesthesia injection. It is also well-tolerated by patients, and the eye is often completely comfortable by the morning after the injection procedure. Injectable treatments often have to be repeated, as, with any medicine, the treatment effect of the injections is transient. Injection therapy similar to laser treatment, is very safe. Like any medical procedure, there are potential risks and side-effects to the injections, and these specific issues will be discussed with each patient on an individualized basis. Recently there has been evidence that after intensive injection therapy there is significant reversal of some signs of diabetic retinopathy, and injection therapy can sometimes be given less frequently over time. As injection therapy for proliferative diabetic retinopathy is relatively new, its role in the treatment of abnormal new blood vessels is going to evolve and change over time. Our practice is active in developing the best practices in injection therapy, and we have presented research involving injection dosing in diabetes at the American Society of Retina Specialists meeting in 2013 and 2014.

Proliferative Diabetic Retinopathy NEWS

Below are current articles from a Google News Feed on Proliferative Diabetic Retinopathy

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

News-Medical.net

Researchers find expression of lymphatic markers in proliferative diabetic retinopathy tissues
News-Medical.net
"We asked whether proliferative diabetic retinopathy involves the growth of new lymphatic vessels in addition to blood vessels - and, indeed, we found expression of lymphatic markers in the PDR tissues." The new study, conducted at the University of ...


Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy
Dove Medical Press
Patients and methods: The subjects in this retrospective, observational, comparative study were 55 consecutive patients (61 eyes) who underwent vitrectomy for proliferative diabetic retinopathy at Toho University Sakura Medical Center between December ...

and more »

WhaTech

Proliferative Diabetic Retinopathy (PDR) Pipeline Therapeutic Development by Clinical Areas 2018
Healthcare Trends
Proliferative Diabetic Retinopathy (PDR) – Pipeline Review, H1 2018 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Diabetic Retinopathy (PDR) – Pipeline Review, H1 2018, provides an overview of the ...
Proliferative Diabetic Retinopathy Therapeutics SalesMarket with Attractiveness, Competitive Landscape and ...The Financial Analyst
Global Proliferative Diabetic Retinopathy Therapeutics Sales Market Industry Analysis, Size, Share, Growth, Trends ...Healthcare Journal
Global proliferative diabetic retinopathy therapeutics market forecast to 2025 insights shared in detailed reportWhaTech

all 4 news articles »

Chicago Evening Post

Key Insights on Global Proliferative Diabetic Retinopathy Market Development and Factors Supporting Growth Through ...
Chicago Evening Post
Albany, NY — 04/18/2018 — Diabetic retinopathy is the most common eye disease associated with diabetes and it's the leading cause of blindness among working-age people. A new research, titled “Proliferative Diabetic Retinopathy Market – Global ...

and more »

Global Proliferative Diabetic Retinopathy Market 2018 Top Players – Cipla, Genentech, Inc. (Roche Holdings ...
Healthcare Trends
Global Proliferative Diabetic Retinopathy Market Research Review 2018. The report consists of historic data based on the Global Proliferative Diabetic Retinopathy Market, spanning from 2013 to 2017 continued up to the forecast year 2023, which has made ...


Proliferative Diabetic Retinopathy Market Competition by Manufacturers
Pharmaceuticals News
Proliferative Diabetic Retinopathy Market research is provided on market opportunities, drivers, trends, challenges, size and share, key players. An absolute analysis of Proliferative Diabetic Retinopathy market delivers actionable intelligence on ...

and more »

MilTech

Proliferative Diabetic Retinopathy Therapeutics Market Dynamics, Forecast, Analysis and Supply Demand 2018-2022
Healthcare Journal
HTF MI recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of Proliferative Diabetic Retinopathy Therapeutics market. The study covers significant data which makes the research document a ...
Proliferative Diabetic Retinopathy Therapeutics Market Analysis including Size, Share, Key Drivers, Growth ...Healthcare Trends
Global Proliferative Diabetic Retinopathy Therapeutics Market 2018 by Top Key Players, Product Type, End-user ...The Financial
Diabetic Retinopathy Market Is Expanding At A CAGR Of 6.7% From 2016 To 2022MilTech

all 13 news articles »

Proliferative Diabetic Retinopathy Market Pipeline Review H1 2018 Drug Profile with Product Description, Mechanism ...
Healthcare Journal
Proliferative Diabetic Retinopathy Market Pipeline Review, H1 2018, tracks core statistics comprising key pipeline therapeutics and drug profiles with mechanism of action (MoA), route of administration (RoA), molecule type as well as Proliferative ...


Technical Progress

Global Proliferative Diabetic Retinopathy Therapeutics Market Analysis, Key Trends, Segments and Value Share 2018 ...
Healthcare Journal
Global Proliferative Diabetic Retinopathy Therapeutics Market Research Report 2018 provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this ...
Global Proliferative Diabetic Retinopathy Therapeutics Market 2018 by Company, Regions, Types and Applications ...Healthcare Trends
Proliferative Diabetic Retinopathy Market to Set Phenomenal Growth from 2018 to 2022Technical Progress
FDA permits marketing of AI-based device to detect diabetic retinopathyEuropean Pharmaceutical Review
MilTech
all 9 news articles »

Global Diabetic Retinopathy Market Growth Analysis in Next Five Years
Medgadget (blog)
Proliferative Diabetic Retinopathy. Diabetic Macular Edema. Based on the drug class, the global diabetic retinopathy treatment market is segmented as: Corticosteroids. Anti-VEGF (vascular endothelial growth factor). Based on the basis distribution ...
Proliferative Diabetic Retinopathy Market to Expand at a CAGR of 9.5% from 2017 – 2026satPRnews (press release)

all 5 news articles »

Proliferative Diabetic Retinopathy Therapeutics Market Highlights, Business Opportunities and Future Growth Outlook ...
Business Services
Global Proliferative Diabetic Retinopathy Therapeutics Market Research Report 2018. The research report presents a comprehensive assessment of the Proliferative Diabetic Retinopathy Therapeutics market and contains thoughtful insights, facts ...


Proliferative Diabetic Retinopathy Therapeutics Sales Market Outlook, Opportunity And Demand Analysis, Forecast ...
Morning Outlook (press release)
Market Insights Reports new study, Global Proliferative Diabetic Retinopathy Therapeutics Sales Market Report 2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its ...

and more »

World Diabetic Retinopathy Market will register healthy growth of 6.5% to beat $ 11 billion by 2024
Markets Insider
SELLBYVILLE, Del., April 9, 2018 /PRNewswire-iReach/ -- The Industry outlook report "Diabetic Retinopathy Market Size, By Type (Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy), By Management (Anti VEGF Drug, Intra-ocular ...
Global Proliferative Diabetic Retinopathy Market to Grow at Over 9.5% CAGR through 2026Pharmaceuticals News

all 6 news articles »

Anti-VEGF Drugs to Remain Preferred for Treatment of Proliferative Diabetic Retinopathy
Pharmaceuticals News
Companies in the global proliferative diabetic retinopathy market are employing strategic initiatives that include product development, geographical expansion, acquisitions, and mergers. These strategies are likely to aid the market players in ...

and more »

WebMD

FDA OKs AI Device to Detect Diabetic Retinopathy
WebMD
The FDA says patients with a history of laser treatment, surgery, or injections in the eye, or those who have any of the following conditions, should not be screened for diabetic retinopathy with the IDx-DR: persistent vision loss, blurred vision ...
FDA OKs AI-Based Device to Detect Diabetic RetinopathyMedPage Today
FDA OKs AI Device to Detect Diabetic Retinopathy in Primary CareMedscape
FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problemsFDA.gov
Monthly Prescribing Reference -UPI.com -Financial Express
all 187 news articles »

Clinical Advisor

FDA Approves AI Device to Detect Diabetic Retinopathy
Clinical Advisor
The software should not be used to screen for diabetic retinopathy in patients who've had laser treatment, surgery, or injection in the eye or have any of the following conditions: persistent vision loss, blurred vision, floaters, previously diagnosed ...

and more »

Virtual-Strategy Magazine

Diabetic Retinopathy Market Expected to be Valued at $10.11 Billion by 2022 | Million Insights
PR Newswire (press release)
On the basis disease type, the global diabetic retinopathy industry can be broadly categorized as proliferative retinopathy and non-proliferative diabetic retinopathy. On the basis of the different treatment techniques, the global diabetic retinopathy ...
Diabetic Retinopathy Market Set to Register 6.5% CAGR During 2017-2024Business Services

all 3 news articles »

Global Proliferative Diabetic Retinopathy Therapeutics Sales market research report with growth, latest trends ...
NB Post Gazette
Questale released a detailed assessment of trends in Global Proliferative Diabetic Retinopathy Therapeutics Sales market. The research report includes diverse topics like total market size, key market drivers, challenges, growth opportunities, key ...

and more »

Proliferative Diabetic Retinopathy (PDR) Global Key Players – Antisense Therapeutics Ltd, Icon Bioscience Inc, Ohr ...
Healthcare Journal
Overview. Proliferative diabetic retinopathy (PDR) is the most severe type of diabetic retinopathy. Proliferative diabetic retinopathy occurs where fragile new blood vessels form on the surface of the retina over time. These abnormal vessels can bleed ...

and more »

Medgadget (blog)

Diabetic Retinopathy Market 5.2% CAGR Expected to Reach by 2023 | Non-Proliferative, Proliferative Type ...
Medgadget (blog)
The Global Diabetic Retinopathy Market is expected to grow at a CAGR of 5.2% during the forecast period. The Global Diabetic Retinopathy Market is driven by the increasing prevalence of diabetes, rising awareness about diabetic retinopathy, and ...

and more »

Global Diabetic Retinopathy Market Outlook Research on Mounting Demand, Geography and Technological ...
Business Services
A new research by MarketResearch.Biz on Diabetic Retinopathy gives complete guidance which provides the most recent Diabetic Retinopathy market patterns like market development openings, size, share and drivers. This Diabetic Retinopathy market report ...

and more »

Healthcare Journal

Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) – Pipeline Review, H1 2018
Healthcare Journal
Report covers products from therapy areas Metabolic Disorders, Ophthalmology and Oncology which include indications Wet (Neovascular / Exudative) Macular Degeneration, Diabetic Macular Edema, Diabetic Nephropathy, Diabetic Retinopathy, Choroidal ...


Proliferative Diabetic Retinopathy (PDR) – Pipeline Review, H1 2018 overview and Therapeutics Development with ...
Healthcare Journal
Proliferative Diabetic Retinopathy (PDR) – Pipeline Review, H1 2018 is latest pipeline review released by HTF MI to provides comprehensive information on the therapeutics under development for Proliferative Diabetic Retinopathy (PDR), complete with ...

and more »

Proliferative Diabetic Retinopathy Market Is Poised to Reach Roughly US $1000 Million by 2026-End
Digital Journal
A new report of Transparency Market Research has profiles key players making notable contribution to expansion of the global market for proliferative diabetic retinopathy, which include Pfizer, Inc., Genentech, Inc. (Roche Holdings), Merck KGaA ...


Proliferative Diabetic Retinopathy Therapeutics Market Outlook 2024, Global Opportunity & Growth Analysis
Ratings Alerts (blog)
According to Market Insights Reports, Proliferative Diabetic Retinopathy Therapeutics Market provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements ...

and more »

FDA Approves Artificial Intelligence-Based Device to Detect Certain Diabetes-Related Eye Problems
P&T Community
Patients who have a history of laser treatment, surgery, or injections in the eye or who have any of the following conditions should not be screened for diabetic retinopathy with IDx-DR: persistent vision loss, blurred vision, floaters, previously ...

and more »

mHealthIntelligence.com

mHealth Replaces The Specialist Consult in Retinopathy Detection
mHealthIntelligence.com
According to that study, the IDx-DR software was 87.4 percent successful in identifying more than mild diabetic retinopathy and was 89.5 percent successful in identifying patients whose eye images did not meet that level. The agency also noted that the ...


Proliferative Diabetic Retinopathy Therapeutics Market Report by Company, Regions, Types and Applications, Global ...
Version of Event
Global Proliferative Diabetic Retinopathy Therapeutics Market Research Report 2018 presents an in-depth assessment of Proliferative Diabetic Retinopathy Therapeutics market including enabling technologies, key trends, market drivers, challenges ...

and more »

Proliferative Diabetic Retinopathy Market Overview with detailed analysis, emerging players, therapeutic landscape ...
Healthcare Journal
Latest research study from HTF MI with title EMEA (Europe, Middle East and Africa) Proliferative Diabetic Retinopathy by Manufacturers, Regions, Type and Application, Forecast to 2023. The Research report presents a complete assessment of the market ...

and more »

Healthcare Journal

Future of Proliferative Diabetic Retinopathy Market including key players Intas Pharmaceuticals, Santen Pharmaceutical
Healthcare Journal
HTF MI recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of Proliferative Diabetic Retinopathy market. The study covers significant data which makes the research document a handy ...

» Load more